Golam Mohi

6PUBLICATIONS
5CO-AUTHORS
Haematological tumoursAutoimmunityMedical infection agents (incl. prions)Molecular targetsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 28, 2026
PIM1 in myeloproliferative neoplasms: potential pathogenic and therapeutic implications.

|Nov 27, 2023
SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm.

Yue Yang, Salar Abbas, Mohammad A Sayem

|Sep 13, 2022
Interleukin-1 contributes to clonal expansion and progression of bone marrow fibrosis in JAK2V617F-induced myeloproliferative neoplasm.

Mohammed Ferdous-Ur Rahman, Yue Yang, Bao T Le

|Nov 06, 2021
Genetic ablation of Pim1 or pharmacologic inhibition with TP-3654 ameliorates myelofibrosis in murine models.

Avik Dutta, Dipmoy Nath, Yue Yang

|Jun 19, 2021
CDK6 Is a Therapeutic Target in Myelofibrosis.

Avik Dutta, Dipmoy Nath, Yue Yang

|Jan 08, 2021
U2af1 is required for survival and function of hematopoietic stem/progenitor cells.

Avik Dutta, Yue Yang, Bao T Le

Pageof 1

Frequent Collaborators

5 joint publications

Avik Dutta

2 joint publications

Mohammad A Sayem

1 joint publications

Chongzhi Zang

1 joint publications

Salar Abbas